Related Experiment Video
Updated: Jan 26, 2026

Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
Exploratory analysis of prognostic factors for lenvatinib in radioiodine-refractory differentiated thyroid cancer
Chiaki Suzuki1, Naomi Kiyota1,2, Yoshinori Imamura1
1Department of Medical Oncology/Hematology, Kobe University Graduate School of Medicine, Kobe, Japan.
Background:
Multitarget kinase inhibitors (m-TKI), including lenvatinib, are now available as treatment options for radioiodine-refractory differentiated thyroid cancer (RR-DTC). However, the optimal timing of treatment initiation with m-TKI in these patients remains to be defined.
Methods:
We retrospectively reviewed the clinical records of 30 consecutive patients with RR-DTC. The relationship between clinical characteristics was evaluated, including tumor growth parameters at pretreatment/post-treatment and efficacy of lenvatinib.
Results:
A total of 26 patients with RR-DTC treated with lenvatinib were evaluable for response and eligible for analysis. From the results of multivariate analysis, baseline tumor size and tumor-related symptoms were independent negative prognostic factors for overall survival (OS) and progression-free survival (PFS). Pretreatment tumor growth parameters were not prognostic for either PFS or OS.
Conclusions:
Patients with RR-DTC with a high tumor burden and tumor-related symptoms had significantly worse prognosis. Greater tumor reduction after starting lenvatinib may lead to better prognosis, irrespective of pretreatment high tumor growth rate.
Insights
Multitarget kinase inhibitors (m-TKI) like lenvatinib treat radioiodine-refractory differentiated thyroid cancer (RR-DTC). High tumor burden and symptoms predict worse outcomes, while lenvatinib-induced tumor reduction may improve prognosis.
Area of Science:
- Oncology
- Endocrinology
Background:
- Multitarget kinase inhibitors (m-TKI) are treatment options for radioiodine-refractory differentiated thyroid cancer (RR-DTC).
- Optimal timing for initiating m-TKI treatment in RR-DTC patients is not yet established.
Purpose of the Study:
- To evaluate the prognostic factors influencing lenvatinib treatment outcomes in patients with RR-DTC.
- To assess the relationship between clinical characteristics, tumor burden, and treatment efficacy.
Main Methods:
- Retrospective review of 30 consecutive RR-DTC patients treated with lenvatinib.
- Multivariate analysis to identify prognostic factors for overall survival (OS) and progression-free survival (PFS).
Main Results:
- Baseline tumor size and symptoms were independent negative prognostic factors for OS and PFS.
- Pretreatment tumor growth rate did not predict PFS or OS.
- Significant tumor reduction post-lenvatinib correlated with better prognosis.
Conclusions:
- High tumor burden and symptoms indicate a worse prognosis in RR-DTC patients treated with lenvatinib.
- Tumor response to lenvatinib, rather than pretreatment growth rate, is a key determinant of patient outcomes.
More Related Videos
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
03:55Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
Related Concept Videos
Transcription Factors
The Thyroid Gland
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
Cancer Survival Analysis
Functions of Thyroid Hormones
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
Synthesis and Regulation of Thyroid Hormones
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Factors Affecting Solubility